Dr. Dimitrios Laurin Wagner
Charité - Universitätsmedizin Berlin
You are here:
Dr. Dimitrios Laurin Wagner's expertise is in genome engineering in primary human cells with a focus on reprogramming of T lymphocytes for therapeutic interventions in cancer, transplantation and autoimmunity, in particular CRISPR-Cas gene editing and Chimeric Antigen Receptors as well as related technologies.
Dr. Dimitrios Laurin Wagner is head of Research and Development at BeCAT and group leader of a junior research group at the BIH Center for Regenerative Therapies (BCRT).
For more information, see WG Wagner on the Concept page, which provides information about the project, structure and working groups of BeCAT.